Showing results (851-860 of 3,636) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|June 29, 2026
Added value of the tumor-stroma ratio to the PREDICT model for breast cancerSophie C Hagenaars, Tom A Hueting, Frederike Dieleman, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Toxicity profile and tolerability of immune checkpoint inhibitors for the treatment of early-stage breast cancer: a systematic review and meta-analysisMaria Inez Dacoregio, Caio Ernesto do Rego Castro, Isadora Mamede, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Beyond the first dose: Systematic review on external beam radiotherapy for locoregional breast cancer recurrenceJana Nano, Yunrong Shen, Luisa Allwohn, et al.
Breast (Edinburgh, Scotland)|July 3, 2026
Antibody-drug conjugates beyond HER2: Translating evidence into practice for HR+ HER2-negative and triple-negative metastatic breast cancerMariana Carvalho Gouveia, Pedro José Galvão Freire, Caio Guilherme Souza Prado, et al.
Breast (Edinburgh, Scotland)|July 14, 2026
The landscape of clonal hematopoiesis of indeterminate potential in long-term breast cancer survivorsLaura Gálvez-Carvajal, Iñaki Comino-Méndez, Esperanza López-López, et al.
Breast (Edinburgh, Scotland)|July 28, 2026
Cardiotoxicity of newer HER2-Directed therapies in breast cancer: A systematic review and meta-analysis of incidence and comparative riskSenthamizhan Sundaramoorthy, Narendhar Gokulanathan, Rona Joseph P, et al.
Breast (Edinburgh, Scotland)|August 7, 2026
Surgical axillary intervention after neoadjuvant systemic therapy (NST) for early-stage breast cancer - Clinical significance of micrometastases: Data from five neoadjuvant studiesFabienne J Warnecke, Johannes Holtschmidt, Andreas Schneeweiss, et al.
Breast (Edinburgh, Scotland)|July 28, 2026
Evolution of male breast cancer treatment: Results from twenty years of BreastSurgANZ Quality Audit dataStephen Kinsey-Trotman, David Walters, Christopher Bierton, et al.
Breast (Edinburgh, Scotland)|August 11, 2026
Radiation therapy trends following breast-conserving surgery in early-stage estrogen receptor-positive breast cancer: particularly in older patients more frequently omittedLotte Bouwman, Erik J Blok, Astrid N Scholten, et al.
Breast (Edinburgh, Scotland)|August 12, 2026
Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trialFrédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, et al.
Pageof 364